Status:
UNKNOWN
The Effects of Sevoflurane and Desflurane on QT Interval Measured With Cardiac Electrophysiological Balance Index
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Sevoflurane
Desflurane
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The primary aim of this study is to compare the effects of sevoflurane and desflurane on the QT interval. The secondary aim of this study is to compare the effects of drugs used in the induction and m...
Eligibility Criteria
Inclusion
- ASA I-II-III risk group
- the operation time is longer than 1 hour in the Urology department.
Exclusion
- bundle branch block in preoperative ECG,
- Non-sinus heart rhythm,
- QT length in preoperative ECG,
- using drugs that cause known QT prolongation ( beta-blocker drugs using will be included),
- development of malignant arrhythmia that will disrupt hemodynamics in the intraoperative period,
- patients with electrolyte disorders,
- patient refusal -
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05225779
Start Date
February 1 2022
End Date
July 1 2022
Last Update
February 7 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.